These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9797083)

  • 1. c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease.
    Reinacher-Schick A; Petrasch S; Longley BJ; Teschendorf C; Graeven U; Schmiegel W
    Ann Hematol; 1998 Sep; 77(3):131-4. PubMed ID: 9797083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
    Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
    Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new c-kit mutation in a case of aggressive mast cell disease.
    Pignon JM; Giraudier S; Duquesnoy P; Jouault H; Imbert M; Vainchenker W; Vernant JP; Tulliez M
    Br J Haematol; 1997 Feb; 96(2):374-6. PubMed ID: 9029028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
    Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
    J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
    Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
    Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R634W KIT Mutation in an Adult With Systemic Mastocytosis.
    Astle JM; Rose MG; Racke FK; Tormey CA; Siddon AJ
    Lab Med; 2017 Aug; 48(3):253-257. PubMed ID: 28520972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
    Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
    J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis.
    Cairoli R; Grillo G; Beghini A; Cornacchini G; Larizza L; Morra E
    Hematol J; 2004; 5(3):273-5. PubMed ID: 15167915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis.
    Afonja O; Amorosi E; Ashman L; Takeshita K
    Ann Hematol; 1998 Oct; 77(4):183-6. PubMed ID: 9829852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
    De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
    Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
    Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
    Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
    Zheng Y; Nong L; Liang L; Wang W; Li T
    Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-kit mutation in a population of patients with mastocytosis.
    Nagata H; Okada T; Worobec AS; Semere T; Metcalfe DD
    Int Arch Allergy Immunol; 1997; 113(1-3):184-6. PubMed ID: 9130517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
    Chan IJ; Tharp MD
    Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis: from a Molecular Point of View.
    Komi DEA; Rambasek T; Wöhrl S
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.